This is our first report on animal health pharma major, Zoetis. Despite the world's volatile external environment and economic unpredictability, Zoetis has performed well from a financial standpoint given to its varied durable portfolio and global reach. However, the last quarter was not great and the company produced disappointing results failing to meet Wall Street expectations in terms of revenues as well as earnings. It delivered a 5% operating revenue increase in Q3, which reflected a decen ....